rethinkPeptides Search
Menu
Study breakdown

Ghrelin, GHRP-6, and Motilin: Comparing Their Gut Motility Effects Head-to-Head

Animal StudyPreliminary evidence
The takeaway

Ghrelin, GHRP-6, and motilin were compared for gastroprokinetic effects, with ghrelin and GHRP-6 stimulating gastric motility through both GHS-R and motilin receptor cross-activation — confirming dual receptor engagement for gut effects.

Key finding

Ghrelin and GHRP-6 stimulated gastric motility in rats through both GHS-R and motilin receptor cross-activation, with efficacy comparable to motilin —

What the researchers found

Ghrelin and GHRP-6 stimulated gastric motility in rats through both GHS-R and motilin receptor cross-activation, with efficacy comparable to motilin — confirming the bidirectional receptor overlap drives GH secretagogue gut motility effects.

Why it matters

Relevant for ghrp, gut-healing, receptor-signaling.

How the study worked

animal-study study on ghrp, gut-healing.

What this study cannot tell us

See abstract.

How to read the evidence

preliminary evidence.

When this study was published

Published in 2005.

The bigger picture

Advances peptide research with clinical implications.

Questions still open

  • Further research needed.
  • Clinical translation to evaluate.

Common questions

What was studied?
Ghrelin, GHRP-6, and Motilin: Comparing Their Gut Motility Effects Head-to-Head
What was found?
Ghrelin, GHRP-6, and motilin were compared for gastroprokinetic effects, with ghrelin and GHRP-6 stimulating gastric motility through both GHS-R and motilin receptor cross-activation — confirming dual receptor engagement for gut effects.

Read the original research

Comparison of the gastroprokinetic effects of ghrelin, GHRP-6 and motilin in rats in vivo and in vitro.

European journal of pharmacology, 515(1-3), 160-8

Citation

Depoortere, Inge; De Winter, Benedicte; Thijs, Theo; De Man, Joris; Pelckmans, Paul; Peeters, Theo. (2005). Comparison of the gastroprokinetic effects of ghrelin, GHRP-6 and motilin in rats in vivo and in vitro.. European journal of pharmacology, 515(1-3), 160-8.